<SEC-DOCUMENT>0000849146-23-000186.txt : 20231016
<SEC-HEADER>0000849146-23-000186.hdr.sgml : 20231016
<ACCEPTANCE-DATETIME>20231016073123
ACCESSION NUMBER:		0000849146-23-000186
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20231016
DATE AS OF CHANGE:		20231016

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				900224471
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		231326218

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14a-investordeckpressr.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icfbd71509252413fbf7c50d12f7a6233_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Schedule 14A Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amendment No. )</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by a party other than the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Check the appropriate box&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Preliminary Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Additional Materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Soliciting Material under &#167;240.14a-12</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">LIFEVANTAGE CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Registrant as Specified In Its Charter)</font></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Payment of Filing Fee (Check all boxes that apply)&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No fee required</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee paid previously with preliminary materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="icfbd71509252413fbf7c50d12f7a6233_71"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">On October 16, 2023, LifeVantage Corporation issued the following press release&#58;</font></div><div style="text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:371px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LifeVantage Sends Letter to Stockholders and Releases Investor Presentation Detailing Success of Ongoing Transformation </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Highlights Decisive Actions Taken by Board to Rebuild Senior Leadership Team and Develop New LV360 Strategy That Is Delivering Results</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Urges Stockholders to Vote &#8220;FOR&#8221; LifeVantage&#8217;s Seven Highly Engaged Directors on the WHITE Universal Proxy Card</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Salt Lake City, UT, October 16, 2023 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq&#58; LFVN) (&#8220;LifeVantage&#8221; or the &#8220;Company,&#8221;), a leading health and wellness company with products designed to activate optimal health processes, today sent a letter to stockholders and released an investor presentation detailing the actions taken by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) over the last three years to rebuild the senior leadership team, develop a new strategic plan and reposition the Company for profitable growth. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These actions have led to significant stockholder value creation, with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LifeVantage stock generating total shareholder returns of more than 100% in 2023</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, making LifeVantage one of the best performing stocks in the United States this year. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Despite these exceptional returns, two stockholders are seeking to replace half the independent directors on the Board. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board encourages all stockholders to vote &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; the Company&#8217;s seven director candidates using the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> proxy card at the Company&#8217;s upcoming 2024 annual meeting of stockholders, scheduled to be held on November 6, 2023.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The investor presentation is available </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/849146/000084914623000184/lfvnoctober2023investorpre.pdf" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">here</a></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The full text of the letter follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 16, 2023</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dear Fellow Stockholders&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over the last three years, the Board of Directors (the &#8220;Board&#8221;) of LifeVantage Corporation (&#8220;LifeVantage,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) has taken actions to rebuild the senior leadership team and develop a comprehensive new strategy to address the Company&#8217;s challenges and opportunities. The culmination of these actions is our new LV360 strategy, which we announced in January 2023. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As you undoubtedly know, this year has been exceptional for LifeVantage and our stockholders. Through October 12, 2023, our stock has generated total shareholder returns of more than 100%, making LifeVantage one of the best performing stocks in the United States this year. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Today, we released a presentation describing how the Board and senior leadership team redirected the Company&#8217;s strategy and operations to produce these exceptional results. The presentation also provides information on our plans to continue our trajectory of extraordinary returns with our new strategy.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The presentation can be viewed by scanning the QR code below or by visiting&#58; https&#58;&#47;&#47;tinyurl.com&#47;t3xtkupz.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:129px;margin-bottom:5pt;vertical-align:text-bottom;width:132px"></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key highlights from the presentation include&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.5pt">The Board took decisive action to rebuild the senior leadership team and develop a new strategy to reposition the Company.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> In recognition of the changes accelerated and amplified by the pandemic, the Board initiated a process to transform the business, beginning by rebuilding the senior leadership team. Since September 2020, we have appointed or promoted nine new senior executives, including our CEO. The Board also enhanced its own composition in February 2022, by appointing Cynthia Latham, who has over 35 years of direct selling, strategic market planning and product development experience. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.5pt">The Board deliberately and systematically strengthened the business in preparation for the launch of our new LV360 strategy.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The Board worked closely with the new leadership team to plan, design and execute a new strategy to address the Company&#8217;s challenges and opportunities. Under the Board&#8217;s stewardship, we developed a new industry-leading, modernized compensation plan, enhanced our digital tools to support consultants, developed and launched additional products to align with customer needs and emerging trends, expanded into new geographies and invested in social media to drive customer and consultant engagement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.5pt">The Company&#8217;s transformation is driving improved results and delivering value for stockholders.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Since the launch of our LV360 strategy, we have reported consecutive quarters of revenue and Adjusted EBITDA growth and higher Adjusted EBITDA margins. Our improved operational performance has created value for stockholders&#59; our stock has generated a total return of more than 100% since the announcement of our LV360 plan in January 2023, and we now trade at a premium valuation multiple to our peers.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.5pt">A group of stockholders (the &#8220;Radoff-Sudbury Group&#8221;) launched a misguided, costly and disruptive proxy contest at a critical time in the Company&#8217;s transformation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Despite our attempts to engage constructively with the Radoff-Sudbury Group for more than two years, it has failed to offer meaningful ideas for improving and growing our business. Nevertheless, we sought to interview the Radoff-Sudbury Group&#8217;s nominees and made good faith attempts at a resolution&#59; all of our efforts have been rejected. Now, the Radoff-Sudbury Group is seeking to replace half of our independent directors, including the Chairman of our Board, the Chair of our Compensation Committee and the three individuals comprising our entire Audit Committee, which we believe would significantly weaken the Board and disrupt our progress.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.5pt">The Radoff-Sudbury Group&#8217;s nominees would not be additive to our Board.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Two of its nominees have large ownership stakes in competing businesses, and its third nominee serves as President of a SPAC that is trying to acquire a direct selling business, which we believe creates multiple potential conflicts of interest. We do not believe any of the Radoff-Sudbury Group nominees would enhance our Board&#59; rather, we believe their election is more likely to destabilize our business and hinder our progress.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Board strongly urges stockholders to vote &#8220;FOR&#8221; ALL of the Company&#8217;s highly qualified and experienced director candidates using the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> universal proxy card.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders who have any questions or need assistance voting their shares are encouraged to contact the Company&#8217;s proxy solicitor, Morrow Sodali LLC, at (800) 662-5200 or </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LFVN.info&#64;investor.morrowsodali.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The LifeVantage Board of Directors</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About LifeVantage Corporation</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Corporation (Nasdaq&#58; LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &#38; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim&#174; family of products, LifeVantage&#174; Omega+, ProBio, IC Bright&#174;, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience&#174; line of skin, hair, bath &#38; body, and targeted relief products. The Company also markets and sells Petandim&#174;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&#174; its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.lifevantage.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cautionary Note Regarding Forward Looking Statements</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to,&#8221; &#8220;goal,&#8221; &#8220;may be,&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and&#47;or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company&#8217;s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company&#8217;s Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q under the caption &#8220;Risk Factors,&#8221; and in other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Important Additional Information</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company, its directors and certain of its executive officers are participants in the solicitation of proxies from the Company&#8217;s stockholders in connection with the 2024 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company filed its definitive proxy statement and a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> universal proxy card with the SEC on September 22, 2023 in connection with any such solicitation of proxies from the Company&#8217;s stockholders.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT, ACCOMPANYING </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> UNIVERSAL PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The Company&#8217;s definitive proxy statement for the Annual Meeting contains information regarding the direct and indirect interests, by security holdings or otherwise, of the Company&#8217;s directors and executive officers in the Company&#8217;s securities. Information regarding subsequent changes to their holdings of the Company&#8217;s securities can be found in the SEC filings on Forms 3, 4 and 5, which are available on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings or through the SEC&#8217;s website at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Information can also be found in the Company&#8217;s other SEC filings, including its Annual Report on Form 10-K for the year ended June 30, 2023, filed on August 28, 2023. Stockholders can obtain the definitive proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC&#8217;s website at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Copies are also available at no charge on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Statement About Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This letter includes information about certain financial measures that are not prepared in accordance with GAAP, including Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin. We define Non-GAAP Adjusted EBITDA as earnings before interest expense, income taxes, depreciation and amortization, stock compensation expense, other income, net, and certain other adjustments and Non-GAAP Adjusted EBITDA margin as Non-GAAP Adjusted EBITDA divided by total revenue. Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin may not be comparable to similarly titled measures reported by other companies.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are presenting Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin because management believes that they provide additional ways to view our operations when considered with both our GAAP results and the reconciliation to net income, which we believe provides a more complete understanding of our business than could be obtained absent this disclosure. Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin are presented solely as supplemental disclosure because&#58; (i) we believe these measures are a useful tool for investors to assess the operating performance of the business without the effect of these items&#59; (ii) we believe that investors will find this data useful in assessing stockholder value&#59; and (iii) we use Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin as benchmarks to evaluate our operating performance or compare our performance to that of our competitors. The use of Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin has limitations and you should not consider these measures in isolation from or as an alternative to the relevant GAAP measure of net income prepared in accordance with GAAP, or as a measure of profitability or liquidity.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The table set forth below presents reconciliation of Non-GAAP Adjusted EBITDA, which is a non-GAAP financial measure to Net Income, our most directly comparable financial measure presented in accordance with GAAP.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investor Relations Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reed Anderson, ICR</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646) 277-1260</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reed.anderson&#64;icrinc.com</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media Relations Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dan McDermott, ICR</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dan.McDermott&#64;icrinc.com</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of GAAP Net Income to Non-GAAP EBITDA and Non-GAAP Adjusted EBITDA&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP Net income</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$                  1,966</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$               (1,416)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest (income) expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(107)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">590</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">901</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">818</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP EBITDA&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,350</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(175)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock compensation expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">946</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">406</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">284</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of investment</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,205</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">368</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(996)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,468</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,899</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP Adjusted EBITDA</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$                  4,818</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$                  1,724</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2.5pt double #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2.5pt double #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Includes $116,000 of accelerated depreciation related to a change in lease term for the year ended June 30, 2023.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Other adjustments breakout&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class-action lawsuit expenses, net of insurance       reimbursement</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(996)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive team litigation and key management severance expenses, net</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">358</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease abandonment</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">368</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(996)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "1 KT# 2(  A$! Q$!_\0
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M4@N\#/'D&7?NX^[C)]*[;X*?\%*/&7PVU5_#/Q?TJYUF.WF,,M\L0@U"U(W
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M836D>+2=L=)(AT[<ICZ&OHHYAA\<E3S".O\ ,M_G_7R/&E@ZV%?/@Y:?RO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH?\ T(5WY?\ [Y1_Q1_-'D9Q_P BW$_X)_\ I+/S?KWG]C'_ )*Y-_V#IO\
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M:C\/_M,>"_MMGLT_Q)9*JZII!;+0L>DB9^]&Q!P>HZ'GKL?M5?\ )N/Q$_[
MT_\ Z#7S$*4Z&)C3J*S37YGNRJ1JT'.#NFF?A#7V?_P2J!_X:#U;_L!3?^C8
MJ^,*GL[ZYT^0R6T\EO(1@M$Y4X],BOU;%4/K-"5&]KH_/L/5]A5C4M>Q_191
M7\[_ /PDVL?]!2\_[_O_ (T?\)-K'_04O/\ O^_^-?(_ZM/_ )^_A_P3Z/\
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M '[G_P!*)*_/ROT#_95_Y(9X?_W[G_THDK[SB_\ W"'^-?E(_(O#;_D<5/\
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MD.!OAZ<@&15!.#P37B'C3Q5>^./%VL>(-0DDEO-2NI+F0R2-(068D+N/) &
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M7^1\WA/]YI^J_,_2+]M[_DU/XB_]>"_^CHZ_#ZOW!_;>_P"34_B+_P!>"_\
MHZ.OP^KP^'/]VG_B_1'JYU_'CZ?JS]#?^"0__(8^)_\ U[Z?_P"A7%?I-7YL
M_P#!(?\ Y#'Q/_Z]]/\ _0KBOTFKYG._]_J?+\D>YE?^Z0^?YL*_ 7X[_P#)
M</B'_P!C%J/_ *4R5^_5?@+\=_\ DN'Q#_[&+4?_ $IDKU>&_P")4]$<&=_!
M#U92^$O_ "5'PC_V%K7_ -'+7[9?M5?\FX_$3_L#3_\ H-?B;\)?^2H^$?\
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MOL<4[X6H_P"Z_P CYG#Z8B"_O+\SZK_X*\?\@?X8?]=]1_\ 0;:OS9K]@O\
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MH>OZ3:^-$M(TAM;RZN&AN0B[N)' ;S#@J 2 <+R23FNWOO\ @K9K%Y9SV_\
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MK[6[&%EC::ZC,6I6F6R2VX#S!M;(#8. N#BOT1^$WQJ\&_&[P\NL>$-:@U.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX<4OD%%%%<IN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
MB5!.1PT*&@H    -24A$4@   F$   )7" (   !4M!2L  !D>$E$051X7NS=
M>7145?;V\4Y(2"+S+"@@*),@S:2"""BCC2B*@HVMV(*THD(#3B J."%B@Z+,
M* +VSPE;Q6X5!1&, C()A!D"A$$"!$("@8SX[K==BY5^J)"SZU;.O3?U?/YR
MN5*[SCU5=;]UDY#ZPV]$1$04R!_P?Q 1$=%_L9%$1$2!L9%$1$2!L9%$1$2!
ML9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$
M1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!
ML9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$
M1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!
ML9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$
M1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!L9%$1$2!>;V19\^>34E)V;]_
M_P'RDN3DY-S<7'RT7/+[DP27&,C1HT?S\O+P]N$G*ROKT*%#N#N!G#QY$F_L
M3'IZ.MY'(+*\[.QLO+$#\G25)RW>#;E*3NSRRI77+SY:7N+I1N[8L>,O?_E+
MC1HURI<O7X$\0QZ.*E6J=.O6[8<??L#'S+J-&S?VZ=/GDDLNP56>1Y9=O7KU
MGCU[KEZ]&J>$#3D?S9T[]^JKKZY<N3)N4"#UZ]<?-6I4:FHJ#M*3-RC#AP^_
M_/++\3X"D2?8====]_'''^.4H,3'Q\O356;R3.(I\G#(Z?WNN^_>OGT[/F:>
MX=U&[MRY4UY.?R /*UVZ],*%"_&1LVC]^O7R&L-E%:9BQ8H__O@CS@H/8\>.
MQ>TP\*<__>GTZ=,X2^/$B1,=.G3 N86)B(AX\\TW<9;2M]]^6Z9,&1Q-7E*G
M3AVY(L)'SAN\V\A^_?KA1I+WM&K5*B,C Q\\6VZYY19<D!DY7^?DY."XXF[3
MIDU!UV+JU*DX3N/55U_%B6;DXF_W[MTXSIBD72Z:<2AYS[WWWHL/GC=XM)$I
M*2DU:];$723OB8Z.7K-F#3Y^5B0E)94K5PX79*94J5*;-V_&B<7=ZZ^_CAMA
M[.:;;\9Q&NW;M\>)QN;.G8OCC,F34YZB.)&\1T[X<MK'Q\\#/-K( P<.5*Q8
M$7>1/&GITJ7X^%F1D) 0].DO(B)B^?+E.+&X&SER)&Z$L=:M6P?]ZT[9V=E-
MFC3!B<8F3)B $XW)DQ/'D2?)"5].^_CX>8!'&WGPX,%*E2KA+I(GL9%^X;"1
M0?_^(1M)A6(C==A('V$C_8*-),]B(W782!]A(_V"C23/8B-UV$@?82/]@HTD
MSV(C==A('V$C_8*-),]B(W782!]A(_V"C23/8B-UV$@?82/]@HTDSV(C==A(
M'V$C_8*-),]B(W782!]A(_V"C23/8B-UV$@?82/]@HTDSV(C==A('V$C_8*-
M),]B(W782!]QJY$K5ZZ,C(S$U9@)ST8.'CP8-\*8DT;FY>5=<\TU.-'8C!DS
M<*(Q-M(OV$@=-M)'W&KDQ(D3<2G&PK"1<C'G)%1.&BF&#AV*$\W$QL:N7;L6
MQQEC(_V"C=1A(WW$E4;NW;NW;MVZN!1C8=C(6;-FX2YH.&SDKEV[:M>NC4,-
M//SPPSA+@XWT"S92AXWT$<N-S,W-C8^/;]&B!:Y#(ZP:F9:6)M?<I4N7QEW0
M<-C(W_[[48[77W]]B1(E<'0!RI4K]_CCCSO\!&\VTB_82!WGC>S3I\\GGWSR
MY9=?_H<*()NS8,&"(4.&Q,;&XO9I.&_D_OW[7W[YY=MOO[U[]^XW%Z9Y\^8E
M2Y;$12B%I)%)24DOOOCB;;?=9K)L5_3HT:-KUZZU:M7"X]=SWDB1E96U=NU:
M?"*>Y]___O<WWWRS;]\^O+V>PT;&Q,3("T1>)CR37(!LCIQLY92+VZ?!1NHX
M;&3OWKV=OY[#QPLOO( [J.&PD2M6K CNNW!..&_D#S_\4+-F39Q;?(6DD?8Y
M;*2\-' B%4">'G+BQ1TTQD;J.&SD^^^_CQ.I8)LV;7)R9>:DD6EI:<V:-<.)
M1<]A(X\?/W[EE5?BT&(M#!LI+PIY:>!$*IB<>'$3C;&1.@X;N6#! IQ(!=N]
M>_=%%UV$FVC,22/ED<)Q5CALY/SY\W%B<1>&C907A;PT<"(5S,G+F8W482-M
M2DQ,=*N1;[SQ!HZSPF$CQXT;AQ.+NS!L9%Q<G+PT<"(5C(VTAXVTR<5&.ODW
MCDXX;.38L6-Q8G''1E*AV$A[V$B;V$@M-M(OV$B;V$A[V$B;V$@M-M(OV$B;
MV$A[V$B;V$@M-M(OV$B;V$A[V$B;V$@M-M(OV$B;V$A[V$B;V$@M-M(OV$B;
MV$A[V$B;V$@M-M(OV$B;V$A[V$B;V$@M-M(OV$B;V$A[V$B;V$@M-M(OV$B;
MV$A[V$B;V$@M-M(OV$B;V$A[V$B;V$BM\&QD7EX>;H3GL9$VL9'VL)$VN=C(
M29,FX3@KI)'Q\?&X&F///_\\3BSNVK9MR^M(NC VTAXVTB87&[EPX4(<9\NL
M6;-P-<:<?$Z>3SWPP .X"W[ 1MK$1MK#1MKD8B//G#G3KET[G&A%FS9M,C(R
M<$$&UJU;5Z9,&1Q7K,G3P\FWIEW$1MK$1MK#1MKD8B/%EBU;FC=OCD.MN/_^
M^T^<.($+NJ#-FS>[M5JWE"M7[NVWW\:-\ DVTB8VTA[7&YF7E[=Z]>J9,V=.
MGCQYBE=-FS;M^^^_S\S,Q-4KN=M(D9J:^NZ[[S[ZZ*,#!P[\6V%Z].A1H4(%
M7$2P&C9L.&+$"-G)Z1<T8\:,M]YZZX$''JA<N3*."%:=.G7Z]NW[X(,/XA%Z
MAJSME5=>V;IU*SY@_N%Z(\^<.;-DR1)Y@N&KUS/D%#=KUJPU:]8X_YTL-M(>
M=QLIUQ;]^O6+BHK"N9[4J5.G/7OVX#%HN-Y(K1T[=G3MVA77X2M///&$O#/
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M1&,__?23D^_(+5RX$"<6=VRDBHN-O....W U?O#]]]_CD1BK6;-F2DH*3O2
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M-6L+LWGSYHR,#+R]&XX?/SYNW#BI>Z&[+1HU:A07%X=[YT#Y\N6ONNHJO)M
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M1&/MV[?'B<:&#AV*XXJ[M6O7&OX8\GR1D9%KUJS!B<9&CAR)$XWYM)$=.G3
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M--:Y<V<<9\N  0-P-594K%CQP($#N!H/8",1&ZG%1JKXM)$K5JQPJY$3)DS
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MO5M.U&;GO/ L&@D::<S.M<"GC4Q+2QOP[XU\^O1I\N3)<B+<H>[G7KQX(==
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ET4@  *S12   K-%(  "L_0^>HYF=ANLJ5@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
